We curate a digest of the latest news in our field for advocates, policymakers, community coalitions and all who work toward shaping policies and practices to effectively prevent substance use and treat addiction.
Private equity firms have acquired stakes in almost one-third of all methadone clinics in the United States in recent years, according to an investigation by STAT. This gives the firms outsize control of the substance use disorder treatment industry.
A new study finds high school students who use both tobacco and marijuana products miss more school and have lower grades than their peers who use one of these substances alone or neither.
Vice President Kamala Harris called on the Department of Health and Human Services and the Department of Justice to quickly reclassify marijuana from a Schedule I to a Schedule III substance, Reuters reports.
Find more of our must-reads in policy news, including opioid treatment programs becoming increasingly backed by private equity firms that oppose the expansion of methadone access.
View our curated digest of the latest research news, including the neutral correlates of the Addictions Neuroclinical Assessment incentive salience factor among individuals with alcohol use disorder.
The opioid overdose antidote naloxone, cleared by the Food and Drug Administration last year for over-the-counter sales, is not always easy to find in pharmacies.
Five Senate committee chairs have sent letters to the chief executives of major convenience stores and their wholesalers, calling on them to remove unauthorized vaping products.
View our curated digest of the latest research news, including the impact of exposure to e-cigarette advertisements and reviews on the progression of use among young adults in the US.
Almost every sector of American society is obstructing use of methadone and buprenorphine to treat opioid use disorder, according to a yearlong investigation by STAT.
An average of 488 people died per day in the U.S. from excessive alcohol consumption in 2020-21, during the height of the COVID-19 pandemic, according to a new report from the Centers for Disease Control and Prevention.
Find more of our must-reads in policy news, including a yearlong investigation concluding that virtually every sector of society is obstructing use of medications for addiction treatment.
View our curated digest of the latest research news, including an evaluation of system and organizational barriers to substance use treatment in the time of an opioid overdose epidemic.
Poison centers in the U.S. reported a large jump in the number of calls related to psilocybin, or “magic mushrooms,” among teens and young adults after several cities and states began decriminalizing the hallucinogen, a new study finds.
Some veterans' groups are urging the Justice Department to ease federal restrictions on marijuana, six months after the Department of Health and Human Services recommended doing so, NBC News reports.
View our curated digest of the latest research news, including the development and initial testing of a digital mindfulness-based intervention for promoting recovery among individuals with substance use disorder.
A new report finds the latest wave of the opioid epidemic involves using multiple substances at the same time, combining fentanyl with either methamphetamine or cocaine, according to KFF Health News.
A new report finds the percentage of overdose deaths linked to smoking substances increased almost 74% between 2020 and 2022, while the percentage involving injections fell.
Increased availability of prescription opioids and other medications such as benzodiazepines are linked to an increase in U.S. suicide rates, a new study concludes.
Find more of our must-reads in policy news, including current and former ONDCP officials voicing concerns with Director Gupta, who they say has created a toxic work environment.
View our curated digest of the latest research news, including the association between maternal tobacco use during pregnancy and child neurocognitive development.
This website uses cookies. We use cookies and similar technologies to give you the best experience. By using this website, you accept our Privacy Policy and Terms of Use.
Get Support
